MedTrace Logo

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

NCT04722341 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2025-12-16

No results posted yet for this study

Summary

The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.

Conditions

Interventions

BEHAVIORAL

Time-Restricted Eating (TRE)

8-hour daily eating period, starting 1-3 hours after waking up

BEHAVIORAL

Control

More than equal to a 12-hour daily eating period

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Alabama at Birmingham

    collaborator OTHER

  • Harvard University

    collaborator OTHER

  • Cedars-Sinai Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04722341 on ClinicalTrials.gov